摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Oxa-6-azaspiro[3.5]nonane hydrochloride | 1414885-19-0

中文名称
——
中文别名
——
英文名称
2-Oxa-6-azaspiro[3.5]nonane hydrochloride
英文别名
2-oxa-8-azaspiro[3.5]nonane;hydrochloride
2-Oxa-6-azaspiro[3.5]nonane hydrochloride化学式
CAS
1414885-19-0
化学式
C7H14ClNO
mdl
——
分子量
163.64
InChiKey
JDMNMAMPXIFZFN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.81
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    21.3
  • 氢给体数:
    2
  • 氢受体数:
    2

文献信息

  • QUINAZOLINE DERIVATIVE AS TYROSINE-KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
    申请人:Xuanzhu Pharma Co., Ltd.
    公开号:EP2716633B1
    公开(公告)日:2017-05-17
  • 3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF A CBL-B INHIBITOR IN COMBINATION WITH A CANCER VACCINE AND/OR ONCOLYTIC VIRUS
    申请人:Nurix Therapeutics, Inc.
    公开号:EP3953346A1
    公开(公告)日:2022-02-16
  • US9586939B2
    申请人:——
    公开号:US9586939B2
    公开(公告)日:2017-03-07
  • US9956222B2
    申请人:——
    公开号:US9956222B2
    公开(公告)日:2018-05-01
  • [EN] 3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF A CBL-B INHIBITOR IN COMBINATION WITH A CANCER VACCINE AND/OR ONCOLYTIC VIRUS<br/>[FR] COMPOSÉS DE PIPÉRIDINE SUBSTITUÉS EN POSITION 3 POUR L'INHIBITION DE CBL-B, ET UTILISATION D'UN INHIBITEUR DE CBL-B EN COMBINAISON AVEC UN VACCIN CONTRE LE CANCER ET/OU UN VIRUS ONCOLYTIQUE
    申请人:NURIX THERAPEUTICS INC
    公开号:WO2020210508A1
    公开(公告)日:2020-10-15
    Compounds, compositions, and methods for use in inhibiting the E3 enzyme Cbl-b in the ubiquitin proteasome pathway are disclosed. The compounds, compositions, and methods can be used to modulate the immune system, to treat diseases amenable to immune system modulation, and for treatment of cells in vivo, in vitro, or ex vivo. Also disclosed are pharmaceutical compositions comprising a Cbl-b inhibitor and a cancer vaccine, as well as methods for treating cancer using a Cbl-b inhibitor and a cancer vaccine; and pharmaceutical compositions comprising a Cbl-b inhibitor and an oncolytic virus, as well as methods for treating cancer using a Cbl-b inhibitor and an oncolytic virus.
查看更多